UHT.NYSEUniversal Health Realty Income Trust

10-Q: Universal Health Realty Income Trust Reports Q1 2025 Results: Revenue Declines Slightly, Net Income Down

Sentiment:

Quarterly Report

📋All filings for Universal Health Realty Income Trust
🔒Login to Follow

Universal Health Realty Income Trust's Q1 2025 results show a slight decrease in revenue and net income compared to Q1 2024, primarily due to decreased occupancy rates at several medical office buildings.

Capital raiseDuring the second quarter of 2024, the company filed a shelf registration statement on Form S-3 registering the offer and sale, from time-to-time, of an indeterminate amount of the common shares of beneficial interest, preferred shares and debt securities up to an aggregate initial offering price of $100 million.No shares were issued under the Form S-3 since the effective date of April 30, 2024 through March 31, 2025.The availability of the potential liquidity under this shelf registration statement depends on investor demand, market conditions and other factors.The company makes no assurance regarding when, or if, it will issue any securities under this registration statement.
Worse than expectedNet income decreased to $4.8 million from $5.3 million in the same period last year.Revenues decreased by 2.4% to $24.5 million during the three-month period ended March 31, 2025, as compared to $25.1 million during the three-month period ended March 31, 2024.FFO decreased to $11.9 million from $12.4 million in the first quarter of 2024.

Summary

  • Universal Health Realty Income Trust (UHT) reported its financial results for the quarter ended March 31, 2025.
  • Net income decreased to $4.8 million from $5.3 million in the same period last year.
  • The decrease in net income is attributed to a net decrease in income generated at various properties and an increase in interest expense.
  • Revenues decreased by 2.4% to $24.5 million, primarily due to decreased occupancy rates at several medical office buildings.
  • Funds From Operations (FFO) decreased to $11.9 million from $12.4 million in the first quarter of 2024.
  • The company had $349.5 million of outstanding borrowings under its $425 million Credit Agreement, leaving $75.5 million of available borrowing capacity.
  • The company declared and paid dividends of $0.735 per share during the first quarter of 2025, totaling approximately $10.2 million.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While there are some negative indicators like decreased revenue and net income, the company remains compliant with its covenants and has available borrowing capacity. The dependence on UHS and external economic factors introduce uncertainty.

Positives

  • The company remains in compliance with all covenants in its Credit Agreement.
  • The company has $75.5 million of available borrowing capacity under its Credit Agreement.
  • Net cash provided by operating activities of $11.6 million was approximately $1.5 million greater than the $10.2 million of dividends paid during the first three months of 2025.

Negatives

  • Net income decreased by $523,000 compared to the same period last year.
  • Revenues decreased by $593,000, or 2.4%, compared to the same period last year.
  • FFO decreased by $483,000 compared to the same period last year.
  • Decreased occupancy rates at several medical office buildings contributed to the revenue decline.

Risks

  • A substantial portion of revenues depends on UHS, comprising approximately 40% of consolidated revenues.
  • Increased interest rates could increase interest expense and unfavorably impact the ability to access capital markets.
  • Inflationary pressures and staffing shortages experienced by tenants could impact their ability to make rental payments.
  • Potential unfavorable tax consequences and reduced income resulting from an inability to complete, within the statutory timeframes, anticipated tax deferred like-kind exchange transactions.
  • Cybersecurity threats, including ransomware attacks targeting healthcare providers, could have a material adverse effect on the business.

Future Outlook

The company expects to finance all capital expenditures and acquisitions and pay dividends utilizing internally generated and additional funds, which may be obtained through borrowings, debt refinancing, or the issuance of equity.

Industry Context

The report acknowledges challenges facing the healthcare industry, including changes in regulations, reimbursement levels, demographic shifts, and competition, which could affect the operators of their facilities.

Comparison to Industry Standards

  • The report mentions that the advisory fee computation remained unchanged for 2025 as compared to 2024 and 2023 based upon a review of our advisory fee and other general and administrative expenses, as compared to an industry peer group.
  • The report mentions that FFO is computed in accordance with standards established by the National Association of Real Estate Investment Trusts (NAREIT).

Related Party Transactions

  • A wholly-owned subsidiary of UHS serves as the Advisor to the Trust under an advisory agreement.
  • Our officers are all employees of UHS through its wholly-owned subsidiary, UHS of Delaware, Inc.
  • Five of our hospital facilities are leased to wholly-owned subsidiaries of UHS, one of our hospital facilities is leased to a joint venture between a wholly-owned subsidiary of UHS and a third party, and subsidiaries of UHS are tenants of twenty medical/office buildings or free-standing emergency departments, that are either wholly or jointly-owned by us.

Stakeholder Impact

  • The company's performance impacts shareholders through dividend payments and stock value.
  • Tenants are affected by the company's ability to maintain and improve properties.
  • The company's relationship with UHS impacts its financial stability and growth prospects.

Next Steps

  • The company will continue to monitor its capital structure and make decisions regarding capital resources based on market conditions and the performance of its properties.
  • Management and the Board of Trustees will continue to consider various factors in determining the amount of dividends to be paid each period.

Key Dates

DateDescription
December 24, 1986Original Advisory Agreement date with UHS of Delaware, Inc.
January 1, 2019Advisory Agreement amended and restated.
March 25, 2020Effective date of $55 million interest rate swap agreement.
July, 2021Date of original Credit Agreement.
April, 2022Northern Nevada Sierra Medical Center opened.
May 15, 2023$55 million interest rate swap agreement modified to replace the benchmark rate from LIBOR to term SOFR.
September 16, 2024Expiration date of two interest rate swap agreements totaling $85 million.
September 30, 2024Second amendment to Credit Agreement, extending maturity date to September 30, 2028, and increasing borrowing capacity to $425 million.
October 2, 2024Effective date of $85 million interest rate swap agreement.
March 31, 2025End of the reporting period for the 10-Q.
April 30, 2024Form S-3 became effective.
May 8, 2025Date of report filing.

Keywords

REIT, healthcare, real estate, UHS, medical office buildings, financial results, dividends, FFO, leasing, income

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.